Jean-Philippe Mathieu
Director/Board Member at Neuromedia SA
Network origin in Jean-Philippe Mathieu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 8 | |
Investsud SA
Investsud SA Investment ManagersFinance INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium.
6
| Holding Company | Investment Managers | 6 |
Caselia SA
Caselia SA HomebuildingConsumer Durables Caselia SA is a Belgian company that specializes in real estate property development and building construction services. The private company is based in Oudergem, Belgium and has subsidiaries in France. Caselia was founded in 2007 and Louis Amory has been the CEO of the company since 2020.
2
| Private Company | Homebuilding | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Philippe Mathieu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Advanced Animal Diagnostics, Inc.
Advanced Animal Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
University of London | College/University | Doctorate Degree | |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Chief Executive Officer | |
The University of Wales | College/University | Graduate Degree | |
Ghent University | College/University | Doctorate Degree Undergraduate Degree | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Undergraduate Degree | |
Université Catholique de Louvain | College/University | Doctorate Degree | |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Director/Board Member | |
Octa+ Group SA
Octa+ Group SA Financial ConglomeratesFinance Part of Bruxelles Finances Et Participations, Octa+ Group SA is an energy supplier based in Sint-Pieters-Woluwe, Belgium. The Belgian company provides the cheapest energy, natural gas, electricity, and fuel oil in Belgium. The company offers gas and electricity supply, tariff calculation, cost estimation, and billing services. Additionally, they provide a multi-brand fuel card, electric charging, refueling, and charging station services. The company was founded in 1999, and the CEOs are Thierry van Coppenolle and Etienne Rigo. | Financial Conglomerates | Director/Board Member | |
Institut Supérieur de l'Aéronautique et de l'Espace | College/University | Graduate Degree | |
Faculté Polytechnique de Mons | College/University | Undergraduate Degree | |
The Open University Business School | College/University | Masters Business Admin | |
Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
The Louvain School of Management | College/University | Undergraduate Degree | |
Carilibel NV
Carilibel NV Environmental ServicesIndustrial Services Carilibel SA engages in recycling compound and friction cords. The company was founded in 2013 and is headquartered in Verviers, Belgium. | Environmental Services | Director/Board Member | |
DoseVue NV
DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Medical Specialties | Director/Board Member | |
Bioxodes SA
Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ViroVet NV
ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Investment Managers | Private Equity Investor | |
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor | |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus Investment Funds is a venture capital firm founded in 2003. The firm headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
Roslin Technologies Ltd.
Roslin Technologies Ltd. BiotechnologyHealth Technology Roslin Technologies Ltd. engages in the provision of agriculture biotechnology solutions. It offers genome sequencing, genotyping, gene editing, transgenics, phenotyping, and bioinformatics. The company is headquartered in Midlothian, the United Kingdom. | Biotechnology | Chief Operating Officer | |
Apaxen SA
Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Director/Board Member | |
AnimAb BV
AnimAb BV BiotechnologyHealth Technology AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020. | Biotechnology | General Counsel | |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
Home EOS NV
Home EOS NV Engineering & ConstructionIndustrial Services Home EOS NV is a company based in Farciennes, Belgium. Home EOS specializes in providing a serene and healthy living environment with effective and ecological acoustic insulation. The Belgian company was founded in 2014 and Pierre P. de Kettenis de Hollaeken has been the CEO of the company since 2016. | Engineering & Construction | Director/Board Member | |
NeuVasQ Biotechnologies SA
NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke. | Pharmaceuticals: Major | Director/Board Member | |
Gepeceron SARL | Director/Board Member | ||
Caselia Development NV
Caselia Development NV Real Estate DevelopmentFinance Caselia Development NV engages in trading and development of properties. The private company is based in Oudergem, Belgium. The Belgian company was founded in 2010. Louis Amory has been the CEO of the company since 2010. | Real Estate Development | Chief Executive Officer Director/Board Member | |
Agricells SA
Agricells SA BiotechnologyHealth Technology Agricells SA is a Belgian company that specializes in research and development for agriculture using biosolutions such as biocontrol, biostimulant, and biofertilizer. The company is based in Marche-en-Famenne, Belgium. The company focuses on innovation, greentech, and biotechnologies in the field of agriculture. Agricells was founded in 2020 by Maxence Semacoy Albertini and Vincent Vandamme, with Maxence Semacoy Albertini serving as the CEO since 2020. | Biotechnology | Director/Board Member | |
Flanders Vaccine | Director/Board Member | ||
Anifera Ltd. | Director/Board Member | ||
Vetsina Animal Diagnostics Ltd. | Chief Executive Officer | ||
The Royal Veterinary College | College/University | Doctorate Degree | |
Henkens Frères NV
Henkens Frères NV Other Consumer ServicesConsumer Services Henkens Frères SA engages in the construction and installation of domestic heating and industrial thermal equipment. The firm's services include boiler making, refrigeration, heating equipments and industrial piping. The company is headquartered in Henri-Chapelle, Belgium. | Other Consumer Services | Director/Board Member |
Statistics
International
Belgium | 28 |
United Kingdom | 8 |
France | 3 |
United States | 2 |
Switzerland | 2 |
Sectoral
Consumer Services | 14 |
Health Technology | 14 |
Finance | 7 |
Industrial Services | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 28 |
Private Equity Investor | 9 |
Chief Executive Officer | 5 |
Undergraduate Degree | 5 |
Doctorate Degree | 4 |
Most connected contacts
- Stock Market
- Insiders
- Jean-Philippe Mathieu
- Company connections